Innovative MicroGlucagon solution aims to transform insulin therapy for patients with type 1 diabetes
Researchers in Trondheim are developing a new drug for diabetics who must take daily insulin injections. The key is a hormone that relaxes the smallest blood vessels inside. Norwegians lead…